Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Smiths Group Plc (SMIN) Ordinary 37 1/2p

Sell:1,380.00p Buy:1,381.00p 0 Change: 1.00p (0.07%)
FTSE 100:1.12%
Market closed Prices as at close on 21 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,380.00p
Buy:1,381.00p
Change: 1.00p (0.07%)
Market closed Prices as at close on 21 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,380.00p
Buy:1,381.00p
Change: 1.00p (0.07%)
Market closed Prices as at close on 21 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Detection, Flex-Tek, Smiths Interconnect and Smiths Medical. John Crane provides mission-critical solutions such as mechanical seals, seal support systems, power transmission couplings and filtration systems for global energy and process industries. Smiths Detection produces detection and screening technologies for the identification of safety and security threats. Flex-Tek provides engineered components that heat and move fluids and gases for aerospace, consumer products, construction, medical and industrial applications. Smiths Interconnect provides electronic components, subsystems, microwave and radio frequency products that provide secure connectivity of critical applications in the defense, aerospace, communications and industrial markets. Smiths Medical offers medical devices and consumables in the select segments of the infusion systems, vascular access and vital care markets.

Contact details

Address:
4th Fl, 11-12 St. James's Square
LONDON
SW1Y 4LB
United Kingdom
Telephone:
+44 (020) 70041600
Website:
https://www.smiths.com/

Important dates

Future events
Final results 28 September 2021 28/09/21
Past events
General meeting 17 September 2021 17/09/21
Interim dividend payment date 14 May 2021 14/05/21
Interim ex-dividend date 08 April 2021 08/04/21
Interim results 26 March 2021 26/03/21
Final dividend payment date 20 November 2020 20/11/20
Interim dividend payment date 20 November 2020 20/11/20
AGM 16 November 2020 16/11/20
Trading Announcement 16 November 2020 16/11/20
Final ex-dividend date 22 October 2020 22/10/20
Interim ex-dividend date 22 October 2020 22/10/20
Annual report 15 October 2020 15/10/20
Final results 24 September 2020 24/09/20

General stock information

EPIC:
SMIN
ISIN:
GB00B1WY2338
Market cap:
£5.48 billion
Shares in issue:
396.48 million
Sector:
General Industrials
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 100,FTSE 350,FTSE All Share,FTSE 350 Higher Yield

Key personnel

  • Paul Keel
    Chief Executive Officer, Director
  • John Shipsey
    Chief Financial Officer, Executive Director
  • Roland Carter
    President, Smiths Detection and Asia Pacific
  • Julian Fagge
    President, Flex-Tek, Group Strategy and M&A Director
  • Paul Harris
    President of Smiths Interconnect
  • Jehanzeb Noor
    Chief Executive Officer, Smiths Medical
  • Jean Vernet
    President - John Crane
  • Melanie Rowlands
    Group General Counsel
  • Sheena Mackay
    Group Human Resources Director
  • John Mills
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.